AVANOS MED INC's ticker is AVNS and the CUSIP is 05350V106. A total of 270 filers reported holding AVANOS MED INC in Q1 2020. The put-call ratio across all filers is 2.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $18,491,662 | -19.9% | 913,998 | +1.2% | 0.02% | -19.0% |
| Q2 2023 | $23,078,210 | -14.5% | 903,295 | -0.7% | 0.02% | -16.0% |
| Q1 2023 | $26,980,720 | +13.8% | 909,221 | +3.8% | 0.02% | +8.7% |
| Q4 2022 | $23,716,997 | +25.0% | 875,887 | +0.6% | 0.02% | +15.0% |
| Q3 2022 | $18,980,000 | -15.9% | 870,524 | +5.4% | 0.02% | -13.0% |
| Q2 2022 | $22,579,000 | -17.8% | 826,163 | +0.7% | 0.02% | 0.0% |
| Q1 2022 | $27,477,000 | -3.5% | 820,060 | -1.6% | 0.02% | +4.5% |
| Q4 2021 | $28,467,000 | +15.8% | 833,393 | +5.0% | 0.02% | +4.8% |
| Q3 2021 | $24,573,000 | +50.2% | 793,532 | +75.3% | 0.02% | +50.0% |
| Q2 2021 | $16,356,000 | -18.3% | 452,627 | -1.8% | 0.01% | -26.3% |
| Q1 2021 | $20,015,000 | -10.2% | 460,848 | -5.6% | 0.02% | -17.4% |
| Q4 2020 | $22,297,000 | +36.0% | 487,999 | -1.2% | 0.02% | +21.1% |
| Q3 2020 | $16,389,000 | +11.2% | 493,689 | -1.5% | 0.02% | +5.6% |
| Q2 2020 | $14,732,000 | +93.1% | 501,356 | +76.8% | 0.02% | +50.0% |
| Q1 2020 | $7,630,000 | +2880.5% | 283,618 | +4856.6% | 0.01% | – |
| Q4 2018 | $256,000 | -34.7% | 5,722 | 0.0% | 0.00% | – |
| Q3 2018 | $392,000 | – | 5,722 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Paradice Investment Management LLC | 2,272,758 | $45,955,167 | 3.94% |
| RGM Capital, LLC | 2,951,691 | $59,683,192 | 2.73% |
| Tributary Capital Management, LLC | 707,122 | $14,298,007 | 1.35% |
| HEARTLAND ADVISORS INC | 573,095 | $12,775,623 | 0.72% |
| WESTWOOD HOLDINGS GROUP INC | 2,109,273 | $42,650 | 0.40% |
| Foundry Partners, LLC | 212,556 | $4,297,882 | 0.27% |
| Keene & Associates, Inc. | 13,675 | $276,509 | 0.22% |
| J. Goldman & Co LP | 231,132 | $4,673,489 | 0.16% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 307,778 | $6,223,271 | 0.15% |
| Invenomic Capital Management LP | 155,936 | $3,153,026 | 0.13% |